Savvy Updates 10/14/24:  GLP-1s, Medtronic Recall, Breakthrough T1D & TCOYD, Sotagliflozin & FDA Appeal, How PBMs Work, CVS Break Up?, Non-D Above TTIR, Tidepool Loop

Savvy Updates 10/14/24: GLP-1s, Medtronic Recall, Breakthrough T1D & TCOYD, Sotagliflozin & FDA Appeal, How PBMs Work, CVS Break Up?, Non-D Above TTIR, Tidepool Loop

In this week’s issue of The Savvy Diabetic:  GLP-1s & T1D: How they work, dosing & pharmacokinetics Medtronic Recall for Reduced Battery Life Breakthrough T1D & TCOYD: Research Highlights Sotagliflozin (for CKD) & FDA Advocacy NOW! How PBMs...
Savvy Updates, 9/23/24: G7 Geofencing Fix, Senseonics Eversense 365, Abbott Ramps Libre3 Production, AI Predicts Retinopathy, SuperCell Medicines, Stem Cell-Enabled Therapy, How to Appeal Insurance Denial, T1D & Brain Development, FTC & PMBs Sue Each Other, ChatGPT for Diagnosis

Savvy Updates, 9/23/24: G7 Geofencing Fix, Senseonics Eversense 365, Abbott Ramps Libre3 Production, AI Predicts Retinopathy, SuperCell Medicines, Stem Cell-Enabled Therapy, How to Appeal Insurance Denial, T1D & Brain Development, FTC & PMBs Sue Each Other, ChatGPT for Diagnosis

In this week’s issue of The Savvy Diabetic:  Geofencing/Dexcom G7 Update! with Jake Leach Senseonics Gets FDA Clearance for 1-year CGM Abbott Ramps Up Libre 3 Production AI Model to Predict Diabetic Retinopathy GC Therapeutics “Supercell”...
Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana Leaves as New Source of Protein Powder

Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana Leaves as New Source of Protein Powder

Continuous Glucose Monitoring (CGM) Sensor Recall: Abbott Diabetes Care Inc Issues Recall for Certain FreeStyle Libre 3 Sensors due to Risk for Inaccurate High Glucose Readings posted by FDA.gov/medical-devices, 5 September 2024. This recall involves removing...
Skip to content